These FDCs, including popular oral therapies combining metformin, glimepiride, voglibose, and dapagliflozin, were previously licensed by various State Licensing Authorities (SLAs) without due approval ...

India's drug regulatory body, CDSCO, has banned 35 fixed-dose combination drugs, including painkillers and anti-diabetics, due to safety concerns. These combinations were manufactured and sold ...

Period pain or toothache lead us to pain relief medications - here's NHS advice on whether it's safe to take ibuprofen and paracetamol at the ...

In a major crackdown on drug safety violations, India’s Central Drugs Standard Control Organisation (CDSCO) has banned 35 fixed-dose combination (FDC) drugs. These include popular formulations ...

Here's the full list of the 35 banned FDCs: Dapagliflozin + Glimepiride + Metformin Cilnidipine + Metoprolol Succinate Etodolac + Paracetamol + Chlorzoxazone ...

Some of the extensively prescribed FDCs in the banned list include dapagliflozin + glimepiride + metformin for diabetes, cilnidipine + metoprolol succinate for hypertension, and dextromethorphan ...

Type 2 diabetes medications include metformin, sulfonylureas, alpha-glucosidase inhibitors, and other medications that change the way your body uses insulin and glucose. Not everyone with type 2 ...

The mean initial glimepiride dose for the whole patient group was 1.6 ± 0.8mg daily. During the observation period the dose was increased to a mean of 2.2 ± 1.1mg. As shown in table IV ...

The efficacy and tolerability of glimepiride was confirmed in this 8-week non-interventional study of patients with type 2 diabetes mellitus. The reduction in HbA 1c levels over the period of the ...